Carmen Lopez-Cabezas, Judith Baguena, Mireia Marcé Briansó, Gemma Gotor, Susana Ceamanos, Tomas Cuñat, Francesc Broto-Puig, Dolors Soy
{"title":"六种静脉混合液用于术后多模式镇痛的相容性及理化稳定性。","authors":"Carmen Lopez-Cabezas, Judith Baguena, Mireia Marcé Briansó, Gemma Gotor, Susana Ceamanos, Tomas Cuñat, Francesc Broto-Puig, Dolors Soy","doi":"10.2147/DDDT.S543730","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the physical-chemical compatibility of six drug combinations used in intravenous multimodal postoperative analgesia under differing storage conditions and different containers.</p><p><strong>Methods: </strong>The analgesic mixtures studied were ternary and quaternary combinations of tramadol and ketamine with dexketoprofen or ketorolac, plus methadone in some mixtures, all diluted in saline solution. Physical compatibility, pH and concentration of drugs (ultra high performance liquid chromatography (UHPLC-DAD)) were determined 48 hours post-preparation (room temperature) and after 30 days (2°-8°C) for the mixtures in polyolefin bags, and after 14 days at room temperature for those mixtures in silicone and polyisoprene elastomers.</p><p><strong>Results: </strong>No physical changes were observed, and pH remained stable throughout the study. For all five drugs in polyolefin bags the recovery percentage remained within the range 95-105%. Regarding mixtures prepared in elastomers, the recovery percentage for tramadol and dexketoprofen stayed within the range 95-105%, while for methadone it was less than 40%. A subsequent extraction with methanol demonstrated the methadone adsorption on the container walls, more pronounced in the silicone than in the polyisoprene reservoirs.</p><p><strong>Conclusion: </strong>Analgesic mixtures of tramadol and ketamine with adjuvants (dexketoprofen or ketorolac, with or without methadone) showed physicochemical stability for 48 hours at room temperature and up to 30 days at 2°-8°C in polyolefin bags. However, the combination of tramadol, dexketoprofen, and methadone was unstable in both tested elastomeric devices due to methadone adsorption, making it unsuitable for clinical use. These findings underscore the critical role of container material in drug stability.</p>","PeriodicalId":11290,"journal":{"name":"Drug Design, Development and Therapy","volume":"19 ","pages":"8041-8048"},"PeriodicalIF":5.1000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12433248/pdf/","citationCount":"0","resultStr":"{\"title\":\"Compatibility and Physico-Chemical Stability of Six Intravenous Mixtures for Postoperative Multimodal Analgesia.\",\"authors\":\"Carmen Lopez-Cabezas, Judith Baguena, Mireia Marcé Briansó, Gemma Gotor, Susana Ceamanos, Tomas Cuñat, Francesc Broto-Puig, Dolors Soy\",\"doi\":\"10.2147/DDDT.S543730\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To evaluate the physical-chemical compatibility of six drug combinations used in intravenous multimodal postoperative analgesia under differing storage conditions and different containers.</p><p><strong>Methods: </strong>The analgesic mixtures studied were ternary and quaternary combinations of tramadol and ketamine with dexketoprofen or ketorolac, plus methadone in some mixtures, all diluted in saline solution. Physical compatibility, pH and concentration of drugs (ultra high performance liquid chromatography (UHPLC-DAD)) were determined 48 hours post-preparation (room temperature) and after 30 days (2°-8°C) for the mixtures in polyolefin bags, and after 14 days at room temperature for those mixtures in silicone and polyisoprene elastomers.</p><p><strong>Results: </strong>No physical changes were observed, and pH remained stable throughout the study. For all five drugs in polyolefin bags the recovery percentage remained within the range 95-105%. Regarding mixtures prepared in elastomers, the recovery percentage for tramadol and dexketoprofen stayed within the range 95-105%, while for methadone it was less than 40%. A subsequent extraction with methanol demonstrated the methadone adsorption on the container walls, more pronounced in the silicone than in the polyisoprene reservoirs.</p><p><strong>Conclusion: </strong>Analgesic mixtures of tramadol and ketamine with adjuvants (dexketoprofen or ketorolac, with or without methadone) showed physicochemical stability for 48 hours at room temperature and up to 30 days at 2°-8°C in polyolefin bags. However, the combination of tramadol, dexketoprofen, and methadone was unstable in both tested elastomeric devices due to methadone adsorption, making it unsuitable for clinical use. These findings underscore the critical role of container material in drug stability.</p>\",\"PeriodicalId\":11290,\"journal\":{\"name\":\"Drug Design, Development and Therapy\",\"volume\":\"19 \",\"pages\":\"8041-8048\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2025-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12433248/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Design, Development and Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/DDDT.S543730\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Design, Development and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DDDT.S543730","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Compatibility and Physico-Chemical Stability of Six Intravenous Mixtures for Postoperative Multimodal Analgesia.
Purpose: To evaluate the physical-chemical compatibility of six drug combinations used in intravenous multimodal postoperative analgesia under differing storage conditions and different containers.
Methods: The analgesic mixtures studied were ternary and quaternary combinations of tramadol and ketamine with dexketoprofen or ketorolac, plus methadone in some mixtures, all diluted in saline solution. Physical compatibility, pH and concentration of drugs (ultra high performance liquid chromatography (UHPLC-DAD)) were determined 48 hours post-preparation (room temperature) and after 30 days (2°-8°C) for the mixtures in polyolefin bags, and after 14 days at room temperature for those mixtures in silicone and polyisoprene elastomers.
Results: No physical changes were observed, and pH remained stable throughout the study. For all five drugs in polyolefin bags the recovery percentage remained within the range 95-105%. Regarding mixtures prepared in elastomers, the recovery percentage for tramadol and dexketoprofen stayed within the range 95-105%, while for methadone it was less than 40%. A subsequent extraction with methanol demonstrated the methadone adsorption on the container walls, more pronounced in the silicone than in the polyisoprene reservoirs.
Conclusion: Analgesic mixtures of tramadol and ketamine with adjuvants (dexketoprofen or ketorolac, with or without methadone) showed physicochemical stability for 48 hours at room temperature and up to 30 days at 2°-8°C in polyolefin bags. However, the combination of tramadol, dexketoprofen, and methadone was unstable in both tested elastomeric devices due to methadone adsorption, making it unsuitable for clinical use. These findings underscore the critical role of container material in drug stability.
期刊介绍:
Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications.
The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas.
Specific topics covered by the journal include:
Drug target identification and validation
Phenotypic screening and target deconvolution
Biochemical analyses of drug targets and their pathways
New methods or relevant applications in molecular/drug design and computer-aided drug discovery*
Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes)
Structural or molecular biological studies elucidating molecular recognition processes
Fragment-based drug discovery
Pharmaceutical/red biotechnology
Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products**
Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development
Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing)
Preclinical development studies
Translational animal models
Mechanisms of action and signalling pathways
Toxicology
Gene therapy, cell therapy and immunotherapy
Personalized medicine and pharmacogenomics
Clinical drug evaluation
Patient safety and sustained use of medicines.